Based on the aforementioned biological mechanisms, we propose the following pathway hypothesis: the atherogenic lipid profile represented by AIP first promotes visceral fat accumulation and central obesity characterised by BMI, with obesity subsequently driving hypertension through the following core mechanisms. The gene discussed is AIP; the disease is obesity due to melanocortin 4 receptor deficiency.